Hearing News

FDA Approves Fennec Hearing Loss Treatment for Pediatric Cancer Patients Treated with Cisplatin

Fennec Pharmaceuticals Inc (NASDAQ:FENC), a specialty pharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) for the company’s unique formulation of sodium

Read More